Donate now
EN FR

Evidence Synthesis and Classification Branch (ESC)

Publications

All recent publications: 2023-2019

 

  1. Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A. D., de Oliveira Araujo, I. B., Berti, E., . . . International Agency for Research on Cancer/World Health, O. (2023). Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720-1748. Leukemia. 37(9): 1944-1951. PMID: 37468552 https://doi.org/10.1038/s41375-023-01962-5    
  2. Bresalier, R. S., Senore, C., Young, G. P., Allison, J., Benamouzig, R., Benton, S., . . . Members of the World Endoscopy Colorectal Cancer Screening New Test Evaluation Expert Working, G. (2023). An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles. Gut. 72(10): 1904-1918. PMID: 37463757 https://doi.org/10.1136/gutjnl-2023-329701
  3. Canberk, S., Field, A., Bubendorf, L., Chandra, A., Cree, I. A., Engels, M., . . . Schmitt, F. C. (2023). A brief review of the WHO reporting system for lung cytopathology. Journal of the American Society of Cytopathology. 12(4): 251-257. PMID: 37156705 https://doi.org/10.1016/j.jasc.2023.04.002         
  4. Cattley, R. C., Kromhout, H., Sun, M., Tokar, E. J., Abdallah, M. A., Bauer, A. K., . . . Schubauer-Berigan, M. K. M. (2023). Carcinogenicity of anthracene, 2-bromopropane, butyl methacrylate, and dimethyl hydrogen phosphite. Lancet Oncology. 24(5): 431-432. PMID: 36966774 https://doi.org/10.1016/S1470-2045(23)00141-9            
  5. Cree, I. A. (2023). Editorial: The new WHO cytopathology reporting systems-extending the WHO classification of tumors. J Am Soc Cytopathol. 12(4): 239-242. PMID: 37244847 https://doi.org/10.1016/j.jasc.2023.04.004         
  6. Cree, I. A., & Khoury, J. D. (2023). WHO or International Consensus Classification: Is the Difference Worth It? Journal of Clinical Oncology. 41(31): 4937-4938. PMID: 37467455 https://doi.org/10.1200/jco.23.01172              
  7. DeBono, N. L., Daniels, R. D., Beane Freeman, L. E., Graber, J. M., Hansen, J., Teras, L. R., . . . Schubauer-Berigan, M. K. (2023). Firefighting and Cancer: A Meta-analysis of Cohort Studies in the Context of Cancer Hazard Identification. Saf Health Work. 14(2): 141-152. PMID: 37389311 https://doi.org/10.1016/j.shaw.2023.02.003          
  8. Gregorio, C., Thakur, S., Camara Rivero, R., Marcia Dos Santos Machado, S., Cuenin, C., Carreira, C., . . . Talukdar, F. R. (2023). Telomere length assessment and molecular characterization of TERT gene promoter in periampullary carcinomas. Gene. 873: 147460. PMID: 37150235 https://doi.org/10.1016/j.gene.2023.147460  
  9. Haycock, P. C., Borges, M. C., Burrows, K., Lemaitre, R. N., Burgess, S., Khankari, N. K., . . . Fatty Acids in Cancer Mendelian Randomization, C. (2023). The association between genetically elevated polyunsaturated fatty acids and risk of cancer. EBioMedicine. 91: 104510. PMID: 37086649 https://doi.org/10.1016/j.ebiom.2023.104510        
  10. Kelly-Reif, K., Bertke, S. J., Daniels, R. D., Richardson, D. B., & Schubauer-Berigan, M. K. (2023). Ionizing radiation and solid cancer mortality among US nuclear facility workers. International Journal of Epidemiology. 52(4): 1015-1024. PMID: 37253388 https://doi.org/10.1093/ije/dyad075      
  11. Kelly-Reif, K., Bertke, S. J., Rage, E., Demers, P. A., Fenske, N., Deffner, V., . . . Richardson, D. B. (2023). Radon and lung cancer in the pooled uranium miners analysis (PUMA): highly exposed early miners and all miners. Occupational and Environmental Medicine. 80(7): 385-391. PMID: 37164624 https://doi.org/10.1136/oemed-2022-108532               
  12. Lennerz, J. K., Salgado, R., Kim, G. E., Sirintrapun, S. J., Thierauf, J. C., Singh, A., . . . Ritterhouse, L. L. (2023). Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML. Clinical Chemistry and Laboratory Medicine. 61(4): 544-557. PMID: 36696602 https://doi.org/10.1515/cclm-2022-1151             
  13. M Filho, A., Turner, M. C., Warnakulasuriya, S., Richardson, D. B., Hosseini, B., Kamangar, F., . . . Schubauer-Berigan, M. K. (2023). The carcinogenicity of opium consumption: a systematic review and meta-analysis. European Journal of Epidemiology. 38(4): 373-389. PMID: 36773182 https://doi.org/10.1007/s10654-023-00969-7        
  14. Malir, F., Pickova, D., Toman, J., Grosse, Y., & Ostry, V. M. (2023). Hazard characterisation for significant mycotoxins in food. Mycotoxin Res. 39(2): 81-93. PMID: 36930431 https://doi.org/10.1007/s12550-023-00478-2    
  15. Mandrik, O., Roitberg, F., Lauby-Secretan, B., Parak, U., Ramadas, K., Varenne, B., . . . Carvalho, A. L. (2023). Perspective on oral cancer screening: Time for implementation research and beyond. J Cancer Policy. 35: 100381. PMID: 36599217 https://doi.org/10.1016/j.jcpo.2022.100381       
  16. Md Nasir, N. D., Koh, V. C. Y., Cree, I. A., Ruiz, B. I. I., Del Aguila, J., Armon, S., . . . Tan, P. H. (2023). Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast. Histopathology. 82(5): 704-712. PMID: 36579383 https://doi.org/10.1111/his.14856     
  17. Menon, S., Moch, H., Berney, D. M., Cree, I. A., Srigley, J. R., Tsuzuki, T., . . . Amin, M. B. (2023). WHO 2022 classification of penile and scrotal cancers: updates and evolution. Histopathology. 82(4): 508-520. PMID: 36221864 https://doi.org/10.1111/his.14824          
  18. Netto, G. J., Amin, M. B., Comperat, E. M., Gill, A. J., Hartmann, A., Moch, H., . . . Berney, D. M. (2023). Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. European Urology. 83(4): 301-303. PMID: 36202687 https://doi.org/10.1016/j.eururo.2022.09.015   
  19. Pedroso, C. M., Normando, A. G. C., Siracusa, C. S., Lauby-Secretan, B., Nethan, S. T., Tomasi, R. A., . . . Santos-Silva, A. R. (2023). Pan-American prevalence of smokeless tobacco use and association with oral potentially malignant disorders and head and neck cancer: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 136(3): 322-332. PMID: 37076380 https://doi.org/10.1016/j.oooo.2023.02.019      
  20. Pega, F., Momen, N. C., Streicher, K. N., Leon-Roux, M., Neupane, S., Schubauer-Berigan, M. K., . . . Villeneuve, P. J. (2023). Global, regional and national burdens of non-melanoma skin cancer attributable to occupational exposure to solar ultraviolet radiation for 183 countries, 2000–2019: A systematic analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Environment International. 181: 108226. PMID: 37945424 https://doi.org/10.1016/j.envint.2023.108226   
  21. Pitman, M. B., Centeno, B. A., Reid, M. D., Saeig, M., Siddiqui, M. T., Layfield, L. J., . . . Field, A. S. (2023). A brief review of the WHO reporting system for pancreaticobiliary cytopathology. J Am Soc Cytopathol. 12(4): 243-250. PMID: 37003924 https://doi.org/10.1016/j.jasc.2023.03.002         
  22. Pitman, M. B., Centeno, B. A., Reid, M. D., Siddiqui, M. T., Layfield, L. J., Perez-Machado, M., . . . Field, A. S. (2023). The World Health Organization Reporting System for Pancreaticobiliary Cytopathology. Acta Cytologica. 67(3): 304-320. PMID: 36516741 https://doi.org/10.1159/000527912       
  23. Riboli, E., Beland, F. A., Lachenmeier, D. W., Marques, M. M., Phillips, D. H., Schernhammer, E., . . . Madia, F. (2023). Carcinogenicity of aspartame, methyleugenol, and isoeugenol. Lancet Oncology. 24(8): 848-850. PMID: 37454664 https://doi.org/10.1016/S1470-2045(23)00341-8             
  24. Richardson, D. B., Leuraud, K., Laurier, D., Gillies, M., Haylock, R., Kelly-Reif, K., . . . Schubauer-Berigan, M. K. (2023). Cancer mortality after low dose exposure to ionising radiation in workers in France, the United Kingdom, and the United States (INWORKS): cohort study. BMJ. 382: e074520. PMID: 37586731 https://doi.org/10.1136/bmj-2022-074520          
  25. Rubin, M. A., Amin, M. B., Comperat, E., Gill, A., Hartman, A., Menon, S., . . . Netto, G. J. (2023). Reply to Yongbao Wei, Haijian Huang, and Liefu Ye’s Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469-82. European Urology. 83(1): e16-e17. PMID: 36202688 https://doi.org/10.1016/j.eururo.2022.09.021   
  26. Schmitt, F. C., Bubendorf, L., Canberk, S., Chandra, A., Cree, I. A., Engels, M., . . . Field, A. S. (2023). The World Health Organization Reporting System for Lung Cytopathology. Acta Cytologica. 67(1): 80-91. PMID: 36509066 https://doi.org/10.1159/000527580               
  27. Schorb, S., Gleiss, K., Wedekind, R., Suonio, E., Kull, A. K., Kuntz, M., . . . Lachenmeier, D. W. (2023). Assessment of Aspartame (E951) Occurrence in Selected Foods and Beverages on the German Market 2000-2022. Foods. 12(11). PMID: 37297402 https://doi.org/10.3390/foods12112156              
  28. Schubauer-Berigan, M. K., Richardson, D. B., Fox, M. P., Fritschi, L., Guseva Canu, I., Pearce, N., . . . Berrington de Gonzalez, A. (2023). IARC-NCI workshop on an epidemiological toolkit to assess biases in human cancer studies for hazard identification: beyond the algorithm. Occupational and Environmental Medicine. 80(3): 119-120. PMID: 36717257 https://doi.org/10.1136/oemed-2022-108724              
  29. Siebert, R., Schuh, A., Ott, G., Cree, I. A., Du, M. Q., Ferry, J., . . . Khoury, J. D. (2023). Response to the Comments from the Groupe Francophone de Cytogenetique Hematologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors. Leukemia. 37(5): 1170-1172. PMID: 36973349 https://doi.org/10.1038/s41375-023-01872-6              
  30. Singh, D., Vignat, J., Lorenzoni, V., Eslahi, M., Ginsburg, O., Lauby-Secretan, B., . . . Vaccarella, S. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 11(2): e197-e206. PMID: 36528031 https://doi.org/10.1016/S2214-109X(22)00501-0            
  31. Turner, M. C., Cogliano, V., Guyton, K., Madia, F., Straif, K., Ward, E. M., & Schubauer-Berigan, M. K. (2023). Research Recommendations for Selected IARC-Classified Agents: Impact and Lessons Learned. Environmental Health Perspectives. 131(10): 105001. PMID: 37902675 https://doi.org/10.1289/ehp12547      
  32. Van Puyvelde, H., Dimou, N., Katsikari, A., Indave Ruiz, B. I., Godderis, L., Huybrechts, I., & De Bacquer, D. (2023). The association between dietary intakes of methionine, choline and betaine and breast cancer risk: A systematic review and meta-analysis. Cancer Epidemiology. 83: 102322. PMID: 36701983 https://doi.org/10.1016/j.canep.2023.102322    
  33. Zablotska, L. B., Richardson, D. B., Golden, A., Pasqual, E., Smith, B., Rage, E., . . . Pawel, D. J. (2023). The epidemiology of lung cancer following radiation exposure. International Journal of Radiation Biology. 99(3): 569-580. PMID: 35947399 https://doi.org/10.1080/09553002.2022.2110321           
  34. Baan, R. A., & Straif, K. (2022). The Monographs Programme of the International Agency for Research on Cancer. A brief history of its Preamble. ALTEX. 39(3): 443-450. PMID: 34164695 https://doi.org/10.14573/altex.2004081         
  35. Beard, J. D., Verdeja, M. A., Bonsrah, D. A., Westfall, S. D., Steege, A. L., & Schubauer-Berigan, M. K. (2022). Crosswalks to Convert US Census Bureau Industry and Occupation Codes, 1980-2018. Epidemiology. 33(2): e8-e9. PMID: 34799471 https://doi.org/10.1097/EDE.0000000000001440            
  36. Berney, D. M., Cree, I., Rao, V., Moch, H., Srigley, J. R., Tsuzuki, T., . . . Tickoo, S. K. (2022). An introduction to the WHO 5th edition 2022 classification of testicular tumours. Histopathology. 81(4): 459-466. PMID: 35502823 https://doi.org/10.1111/his.14675               
  37. Bouvard, V., Nethan, S. T., Singh, D., Warnakulasuriya, S., Mehrotra, R., Chaturvedi, A. K., . . . Lauby-Secretan, B. (2022). IARC Perspective on Oral Cancer Prevention. New England Journal of Medicine. 387(21): 1999-2005. PMID: 36378601 https://doi.org/10.1056/NEJMsr2210097             
  38. Bouvard, V., Wentzensen, N., Mackie, A., Berkhof, J., Brotherton, J., Giorgi-Rossi, P., . . . Lauby-Secretan, B. (2022). The IARC Perspective on Cervical Cancer Screening. Obstetrical and Gynecological Survey. 77(3): 154-156. PMID: https://doi.org/10.1097/Ogx.0000000000001017            
  39. Cierco Jimenez, R., Lee, T., Rosillo, N., Cordova, R., Cree, I. A., Gonzalez, A., & Indave Ruiz, B. I. (2022). Machine learning computational tools to assist the performance of systematic reviews: A mapping review. BMC Medical Research Methodology. 22(1): 322. PMID: 36522637 https://doi.org/10.1186/s12874-022-01805-4        
  40. Comperat, E., Amin, M. B., Berney, D. M., Cree, I., Menon, S., Moch, H., . . . Tsuzuki, T. (2022). What’s new in WHO fifth edition – urinary tract. Histopathology. 81(4): 439-446. PMID: 35942645 https://doi.org/10.1111/his.14764             
  41. Cree, I. A. (2022). The WHO classification of haematolymphoid tumours: response to Swerdlow et al. Leukemia. 36(11): 2750. PMID: 36171281 https://doi.org/10.1038/s41375-022-01694-y    
  42. Cree, I. A. (2022). The WHO Classification of Haematolymphoid Tumours. Leukemia. 36(7): 1701-1702. PMID: 35732830 https://doi.org/10.1038/s41375-022-01625-x          
  43. Cree, I. A. (2022). From Counting Mitoses to Ki67 Assessment: Technical Pitfalls in the New WHO Classification of Endocrine and Neuroendocrine Tumors. Endocrine Pathology. 33(1): 3-5. PMID: 35028827 https://doi.org/10.1007/s12022-021-09701-1            
  44. Del Aguila Mejia, J., Armon, S., Campbell, F., Colling, R., Chechlinska, M., Kowalewska, M., . . . Indave Ruiz, B. I. (2022). Understanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lung. BMJ Open. 12(10): e061240. PMID: 36220326 https://doi.org/10.1136/bmjopen-2022-061240               
  45. Demers, P. A., DeMarini, D. M., Fent, K. W., Glass, D. C., Hansen, J., Adetona, O., . . . Schubauer-Berigan, M. K. (2022). Carcinogenicity of occupational exposure as a firefighter. Lancet Oncology. 23(8): 985-986. PMID: 35780778 https://doi.org/10.1016/S1470-2045(22)00390-4             
  46. Goodman, S., Chappell, G., Guyton, K. Z., Pogribny, I. P., & Rusyn, I. (2022). Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: An update of a systematic literature review. Mutat Res Rev Mutat Res. 789: 108408. PMID: 35690411 https://doi.org/10.1016/j.mrrev.2021.108408      
  47. Guseva Canu, I., Gaillen-Guedy, A., Antilla, A., Charles, S., Fraize-Frontier, S., Luce, D., . . . Richardson, D. B. (2022). Lung cancer mortality in the European cohort of titanium dioxide workers: a reanalysis of the exposure-response relationship. Occupational and Environmental Medicine. 79(9): 637-640. PMID: 35501125 https://doi.org/10.1136/oemed-2021-108030    
  48. Indave, B. I., Colling, R., Campbell, F., Tan, P. H., & Cree, I. A. (2022). Evidence-levels in pathology for informing the WHO classification of tumours. Histopathology. 81(4): 420-425. PMID: 36089568 https://doi.org/10.1111/his.14648     
  49. Indave Ruiz, B. I., Armon, S., Watanabe, R., Uttley, L., White, V. A., Lazar, A. J., & Cree, I. A. (2022). Clonality, Mutation and Kaposi Sarcoma: A Systematic Review. Cancers. 14(5): 14. PMID: 35267506 https://doi.org/10.3390/cancers14051201    
  50. Karagas, M. R., Wang, A., Dorman, D. C., Hall, A. L., Pi, J., Sergi, C. M., . . . Schubauer-Berigan, M. K. (2022). Carcinogenicity of cobalt, antimony compounds, and weapons-grade tungsten alloy. Lancet Oncology. 23(5): 577-578. PMID: 35397803 https://doi.org/10.1016/S1470-2045(22)00219-4             
  51. Kelly-Reif, K., Bertke, S., Daniels, R. D., Richardson, D. B., & Schubauer-Berigan, M. K. (2022). Nonmalignant respiratory disease mortality in male Colorado Plateau uranium miners, 1960-2016. American Journal of Industrial Medicine. 65(10): 773-782. PMID: 35941829 https://doi.org/10.1002/ajim.23419  
  52. Kelly-Reif, K., Bertke, S. J., Samet, J., Sood, A., & Schubauer-Berigan, M. K. (2022). Health burdens of uranium miners will extend beyond the radiation exposure compensation act deadline. Occupational and Environmental Medicine. 79(7): 503-504. PMID: 35501126 https://doi.org/10.1136/oemed-2022-108311              
  53. Kelly-Reif, K., Sandler, D. P., Shore, D., Schubauer-Berigan, M., Troester, M., Nylander-French, L., & Richardson, D. B. (2022). Lung and extrathoracic cancer incidence among underground uranium miners exposed to radon progeny in the Pribram region of the Czech Republic: a case-cohort study. Occupational and Environmental Medicine. 79(2): 102-108. PMID: 34417337 https://doi.org/10.1136/oemed-2021-107392               
  54. Kench, J. G., Amin, M. B., Berney, D. M., Comperat, E. M., Cree, I. A., Gill, A. J., . . . Srigley, J. R. (2022). WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer. Histopathology. 81(4): 447-458. PMID: 35758185 https://doi.org/10.1111/his.14711        
  55. Lauby-Secretan, B., Mackie, A., & Wentzensen, N. (2022). The IARC Perspective on Cervical Cancer Screening. Reply. New England Journal of Medicine. 386(6): 607-608. PMID: 35139285 https://doi.org/10.1056/NEJMc2119177         
  56. Lobo, J., Ohashi, R., Amin, M. B., Berney, D. M., Comperat, E. M., Cree, I. A., . . . Moch, H. (2022). WHO 2022 landscape of papillary and chromophobe renal cell carcinoma. Histopathology. 81(4): 426-438. PMID: 35596618 https://doi.org/10.1111/his.14700               
  57. Luchini, C., Pantanowitz, L., Adsay, V., Asa, S. L., Antonini, P., Girolami, I., . . . Scarpa, A. (2022). Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring. Modern Pathology. 35(6): 712-720. PMID: 35249100 https://doi.org/10.1038/s41379-022-01055-1  
  58. Martins, B., Normando, A. G. C., Rodrigues-Fernandes, C. I., Wagner, V. P., Kowalski, L. P., Marques, S. S., . . . Santos-Silva, A. R. N. (2022). Global frequency and epidemiological profile of electronic cigarette users: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 134(5): 548-561. PMID: 36182650 https://doi.org/10.1016/j.oooo.2022.07.019      
  59. Menon, S., Moch, H., Berney, D. M., Cree, I. A., Srigley, J. R., Tsuzuki, T., . . . Amin, M. B. (2022). WHO 2022 classification of penile and scrotal cancers: updates and evolution. Histopathology. 82(4): 508-520. PMID: 36221864 https://doi.org/10.1111/his.14824          
  60. Michels, N., Zouiouich, S., Vanderbauwhede, B., Vanacker, J., Indave Ruiz, B. I., & Huybrechts, I. (2022). Human microbiome and metabolic health: An overview of systematic reviews. Obesity Reviews. 23(4): e13409. PMID: 34978141 https://doi.org/10.1111/obr.13409         
  61. Middleton, D. R. S., Mmbaga, B. T., Menya, D., Dzamalala, C., Nyakunga-Maro, G., Finch, P., . . . Esccape (2022). Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. Lancet Glob Health. 10(2): e236-e245. PMID: 34921758 https://doi.org/10.1016/S2214-109X(21)00506-4        
  62. Moch, H., Amin, M. B., Berney, D. M., Comperat, E. M., Gill, A. J., Hartmann, A., . . . Netto, G. J. N. (2022). The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. European Urology. 82(5): 458-468. PMID: 35853783 https://doi.org/10.1016/j.eururo.2022.06.016   
  63. Netto, G. J., Amin, M. B., Berney, D. M., Comperat, E. M., Gill, A. J., Hartmann, A., . . . Moch, H. (2022). The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. European Urology. 82(5): 469-482. PMID: 35965208 https://doi.org/10.1016/j.eururo.2022.07.002   
  64. Paglioni, M. P., Khurram, S. A., Ruiz, B. I. I., Lauby-Secretan, B., Normando, A. G., Ribeiro, A. C. P., . . . Santos-Silva, A. R. (2022). Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 134(5): 573-587. PMID: 36153299 https://doi.org/10.1016/j.oooo.2022.07.006  
  65. Paglioni, M. P., Khurram, S. A., Ruiz, B. I. I., Lauby-Secretan, B., Normando, A. G., Ribeiro, A. C. P., . . . Santos-Silva, A. R. N. (2022). Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 134(5): 573-587. PMID: 36153299 https://doi.org/10.1016/j.oooo.2022.07.006  
  66. Pfister, S. M., Reyes-Mugica, M., Chan, J. K. C., Hasle, H., Lazar, A. J., Rossi, S., . . . Alaggio, R. (2022). A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era. Cancer Discovery. 12(2): 331-355. PMID: 34921008 https://doi.org/10.1158/2159-8290.CD-21-1094   
  67. Pinello, K., Baldassarre, V., Steiger, K., Paciello, O., Pires, I., Laufer-Amorim, R., . . . Dagli, M. L. Z. (2022). Vet-ICD-O-Canine-1, a System for Coding Canine Neoplasms Based on the Human ICD-O-3.2. Cancers. 14(6). PMID: 35326681 https://doi.org/10.3390/cancers14061529          
  68. Reisfeld, B., de Conti, A., El Ghissassi, F., Benbrahim-Tallaa, L., Gwinn, W., Grosse, Y., & Schubauer-Berigan, M. (2022). kc-hits: a tool to aid in the evaluation and classification of chemical carcinogens. Bioinformatics. 38(10): 2961-2962. PMID: 35561175 https://doi.org/10.1093/bioinformatics/btac189         
  69. Richardson, D. B., Rage, E., Demers, P. A., Do, M. T., Fenske, N., Deffner, V., . . . Laurier, D. (2022). Lung Cancer and Radon: Pooled Analysis of Uranium Miners Hired in 1960 or Later. Environmental Health Perspectives. 130(5): 57010. PMID: 35604341 https://doi.org/10.1289/EHP10669         
  70. Samet, J. M., Berrington de Gonzalez, A., Lunn, R. M., & Schubauer-Berigan, M. K. (2022). Commentary: Role and communications of cancer hazard determinations. Carcinogenesis. 43(2): 79-81. PMID: 35016221 https://doi.org/10.1093/carcin/bgac001              
  71. Thierauf, J. C., Farahani, A. A., Indave, B. I., Bard, A. Z., White, V. A., Smith, C. R., . . . Lennerz, J. K. (2022). Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma. International Journal of Molecular Sciences. 23(8): 4322. PMID: 35457138 https://doi.org/10.3390/ijms23084322            
  72. White, V. A., Hyrcza, M. D., Lennerz, J. K., Thierauf, J., Lokuhetty, D., Cree, I. A., & Indave, B. I. (2022). Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities? Modern Pathology. 35(10): 1484-1493. PMID: 35871081 https://doi.org/10.1038/s41379-022-01100-z               
  73. Yadav, K., Cree, I., Field, A., Vielh, P., & Mehrotra, R. (2022). Importance of Cytopathologic Diagnosis in Early Cancer Diagnosis in Resource-Constrained Countries. JCO Glob Oncol. 8: e2100337. PMID: 35213215 https://doi.org/10.1200/GO.21.00337        
  74. Barupal, D. K., Schubauer-Berigan, M. K., Korenjak, M., Zavadil, J., & Guyton, K. Z. (2021). Prioritizing cancer hazard assessments for IARC Monographs using an integrated approach of database fusion and text mining. Environ Int. 156: 106624. PMID: 33984576  doi: 10.1016/j.envint.2021.106624
  75. Bilal, M., Raza, S. E. A., Azam, A., Graham, S., Ilyas, M., Cree, I. A., . . . Rajpoot, N. M. (2021). Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer from routine histology images: a retrospective study. Lancet Digit Health. 3(12): e763-e772. PMID: 34686474  doi: 10.1016/S2589-7500(21)00180-1
  76. Bouvard, V., Wentzensen, N., Mackie, A., Berkhof, J., Brotherton, J., Giorgi-Rossi, P., . . . Lauby-Secretan, B. (2021). The IARC Perspective on Cervical Cancer Screening. N Engl J Med. 385(20): 1908-1918. PMID: 34758259  doi: 10.1056/NEJMsr2030640
  77. Bruford, E. A., Antonescu, C. R., Carroll, A. J., Chinnaiyan, A., Cree, I. A., Cross, N. C. P., . . . Mitelman, F. (2021). HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions. Leukemia. 35(11): 3040-3043. PMID: 34615987  doi: 10.1038/s41375-021-01436-6
  78. Chow, Z. L., Indave, B. I., Lokuhetty, M. D. S., Ochiai, A., Cree, I. A., & White, V. A. (2021). Misleading terminology in pathology: lack of definitions hampers communication. Virchows Arch. 479(2): 425-430. PMID: 33796909  doi: 10.1007/s00428-021-03069-7
  79. Chow, Z. L., Indave, B. I., Lokuhetty, M. D. S., Ochiai, A., Cree, I. A., & White, V. A. (2021). Correction to: Misleading terminology in pathology: Lack of definitions hampers communication. Virchows Arch. 479(2): 439. PMID: 33890126  doi: 10.1007/s00428-021-03101-w
  80. Cree, I. A., Indave Ruiz, B. I., Zavadil, J., McKay, J., Olivier, M., Kozlakidis, Z., . . . participants, I. R. (2021). The International Collaboration for Cancer Classification and Research. Int J Cancer. 148(3): 560-571. PMID: 32818326  doi: 10.1002/ijc.33260
  81. Cree, I. A., Tan, P. H., Travis, W. D., Wesseling, P., Yagi, Y., White, V. A., . . . Scolyer, R. A. (2021). Counting mitoses: SI(ze) matters! Mod Pathol. 34(9): 1651-1657. PMID: 34079071  doi: 10.1038/s41379-021-00825-7
  82. Fraser, K., Hubbs, A., Yanamala, N., Mercer, R. R., Stueckle, T. A., Jensen, J., . . . Erdely, A. (2021). Histopathology of the broad class of carbon nanotubes and nanofibers used or produced in U.S. facilities in a murine model. Part Fibre Toxicol. 18(1): 47. PMID: 34923995  doi: 10.1186/s12989-021-00440-z
  83. Guyton, K. Z., & Schubauer-Berigan, M. K. (2021). Invited Perspective: Prioritizing Chemical Testing and Evaluation Using Validated in Vitro Assays Relevant to Key Characteristics. Environ Health Perspect. 129(7): 71303. PMID: 34287027  doi: 10.1289/EHP9507
  84. Jimenez, R. C., Casajuana-Martin, N., Garcia-Recio, A., Alcantara, L., Pardo, L., Campillo, M., & Gonzalez, A. (2021). The mutational landscape of human olfactory G protein-coupled receptors. BMC Biol. 19(1): 21. PMID: 33546694  doi: 10.1186/s12915-021-00962-0
  85. Le Curieux, F., Gohlke, J. M., Pronk, A., Andersen, W. C., Chen, G. S., Fang, J. L., . . . grp, I. M. V. (2021). Carcinogenicity of gentian violet, leucogentian violet, malachite green, leucomalachite green, and CI Direct Blue 218. Lancet Oncol. 22(5): 585-586. PMID: 33773614  doi: 10.1016/s1470-2045(21)00178-91
  86. Leske, H., Dalgleish, R., Lazar, A. J., Reifenberger, G., & Cree, I. A. (2021). A common classification framework for histone sequence alterations in tumours: an expert consensus proposal. J Pathol. 254(2): 109-120. PMID: 33779999  doi: 10.1002/path.5666
  87. Leuraud, K., Richardson, D. B., Cardis, E., Daniels, R. D., Gillies, M., Haylock, R., . . . Laurier, D. (2021). Risk of cancer associated with low-dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A-bomb survivors study. Radiat Environ Biophys. 60(1): 23-39. PMID: 33479781  doi: 10.1007/s00411-020-00890-7
  88. Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., . . . Ellison, D. W. (2021). The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 23(8): 1231-1251. PMID: 34185076  doi: 10.1093/neuonc/noab106
  89. Matos, L. L., Forster, C. H. Q., Marta, G. N., Castro Junior, G., Ridge, J. A., Hirata, D., . . . Kowalski, L. P. (2021). The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying-the head and neck cancer model. Cancer Causes Control. 32(5): 459-471. PMID: 33704627  doi: 10.1007/s10552-021-01411-7
  90. Michels, N., De Backer, F., Dimakopoulou, M., Mane, K., Indave, I., & Huybrechts, I. (2021). Eating disorders and the risk of developing cancer: a systematic review. Eat Weight Disord. 26(4): 1021-1035. PMID: 33025526  doi: 10.1007/s40519-020-01020-4
  91. Mostovenko, E., Dahm, M. M., Schubauer-Berigan, M. K., Eye, T., Erdely, A., Young, T. L., . . . Ottens, A. K. (2021). Serum peptidome: diagnostic window into pathogenic processes following occupational exposure to carbon nanomaterials. Part Fibre Toxicol. 18(1): 39. PMID: 34711247  doi: 10.1186/s12989-021-00431-0
  92. Reynolds, R. R., Davies, M. J., Buffam, F. V., Dolman, P. J., & White, V. A. (2021). Differences in 7th and 8th edition American Joint Committee on Cancer staging for periocular sebaceous carcinoma. Can J Ophthalmol. 56(1): 31-36. PMID: 32822657  doi: 10.1016/j.jcjo.2020.07.017
  93. Richardson, D. B., Rage, E., Demers, P. A., Do, M. T., DeBono, N., Fenske, N., . . . Laurier, D. (2021). Mortality among uranium miners in North America and Europe: the Pooled Uranium Miners Analysis (PUMA). Int J Epidemiol. 50(2): 633-643. PMID: 33232447  doi: 10.1093/ije/dyaa195
  94. Rusyn, I., Arzuaga, X., Cattley, R. C., Corton, J. C., Ferguson, S. S., Godoy, P., . . . Smith, M. T. (2021). Key Characteristics of Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver Toxicity. Hepatology. 74(6): 3486-3496. PMID: 34105804  doi: 10.1002/hep.31999
  95. Washington, M. K., Goldberg, R. M., Chang, G. J., Limburg, P., Lam, A. K., Salto-Tellez, M., . . . Board, W. H. O. C. o. T. E. (2021). Diagnosis of digestive system tumours. Int J Cancer. 148(5): 1040-1050. PMID: 32674220  doi: 10.1002/ijc.33210
  96. Arroyave, W. D., Mehta, S. S., Guha, N., Schwingl, P., Taylor, K. W., Glenn, B., . . . Lunn, R. M. (2020). Challenges and recommendations on the conduct of systematic reviews of observational epidemiologic studies in environmental and occupational health. J Expo Sci Environ Epidemiol. 31(1): 21-30. PMID: 32415298 doi: 10.1038/s41370-020-0228-0
  97. Cree, I. A., White, V. A., Indave, B. I., & Lokuhetty, D. (2020). Revising the WHO classification: female genital tract tumours. Histopathology. 76(1): 151-156. PMID: 31846528 doi: 10.1111/his.13977
  98. Elder, D. E., Bastian, B. C., Cree, I. A., Massi, D., & Scolyer, R. A. (2020). The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. Arch Pathol Lab Med. 144(4): 500-522. PMID: 32057276 doi: 10.5858/arpa.2019-0561-RA
  99. Fraser, K., Kodali, V., Yanamala, N., Birch, M. E., Cena, L., Casuccio, G., . . . Erdely, A. (2020). Physicochemical characterization and genotoxicity of the broad class of carbon nanotubes and nanofibers used or produced in U.S. facilities. Part Fibre Toxicol. 17(1): 62. PMID: 33287860 doi: 10.1186/s12989-020-00392-w
  100. Ge, C., Peters, S., Olsson, A., Portengen, L., Schüz, J., Almansa, J., . . . Vermeulen, R. (2020). Diesel Engine Exhaust Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Exposure-Response Analysis of 14 Case-Control Studies. Am J Respir Crit Care Med. 202(3): 402-411. PMID: 32330395 doi: 10.1164/rccm.201911-2101OC
  101. Ge, C., Peters, S., Olsson, A., Portengen, L., Schuz, J., Almansa, J., . . . Vermeulen, R. (2020). Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case-Control Studies. Am J Respir Crit Care Med. 202(3): 412-421. PMID: 32330394 doi: 10.1164/rccm.201910-1926OC
  102. Gonzalez-Ericsson, P. I., Stovgaard, E. S., Sua, L. F., Reisenbichler, E., Kos, Z., Carter, J. M., . . . International Immuno-Oncology Biomarker Working, G. (2020). The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice. J Pathol. 250(5): 667-684. PMID: 32129476 doi: 10.1002/path.5406
  103. Guseva Canu, I., Gaillen-Guedy, A., Wild, P., Straif, K., & Luce, D. (2020). Lung cancer mortality in the French cohort of titanium dioxide workers: some aetiological insights. Occup Environ Med. 77(11): 795-797. PMID: 32737152 doi: 10.1136/oemed-2020-106522
  104. Hall, A. L., Kromhout, H., Schuz, J., Peters, S., Portengen, L., Vermeulen, R., . . . Olsson, A. (2020). Laryngeal Cancer Risks in Workers Exposed to Lung Carcinogens: Exposure-Effect Analyses Using a Quantitative Job Exposure Matrix. Epidemiology. 31(1): 145-154. PMID: 31577634 doi: 10.1097/ede.0000000000001120
  105. Huybrechts, I., Zouiouich, S., Loobuyck, A., Vandenbulcke, Z., Vogtmann, E., Pisanu, S., . . . Michels, N. (2020). The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 29(10): 1856-1868. PMID: 32727720 doi: 10.1158/1055-9965.EPI-20-0288
  106. IARC Monographs Vol 126 group (2020). Carcinogenicity of opium consumption. Lancet Oncol. 21(11): 1407-1408. PMID: 33038940 doi: 10.1016/s1470-2045(20)30611-2
  107. Kelly-Reif, K., Sandler, D. P., Shore, D., Schubauer-Berigan, M. K., Troester, M. A., Nylander-French, L., & Richardson, D. B. (2020). Radon and cancer mortality among underground uranium miners in the Pribram region of the Czech Republic. American Journal of Industrial Medicine. 63(10): 859-867. PMID: 33448434 doi: 10.1002/ajim.23167
  108. La Merrill, M. A., Vandenberg, L. N., Smith, M. T., Goodson, W., Browne, P., Patisaul, H. B., . . . Zoeller, R. T. (2020). Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat Rev Endocrinol. 16(1): 45-57. PMID: 31719706 doi: 10.1038/s41574-019-0273-8
  109. Lokuhetty, M. D. S., Wijesinghe, H. D., Damen, J. A. A. G., Lee, T., Whiter, V. A., Cree, I. A., & Indave, B. I. (2020). Prognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast cancer. Cochrane Database of Systematic Reviews(11): 18. doi: 10.1002/14651858.CD013784
  110. Louis, D. N., Wesseling, P., Aldape, K., Brat, D. J., Capper, D., Cree, I. A., . . . Ellison, D. W. (2020). cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol. 30(4): 844-856. PMID: 32307792 doi: 10.1111/bpa.12832
  111. Mahmood, H., Shaban, M., Indave, B. I., Santos-Silva, A. R., Rajpoot, N., & Khurram, S. A. (2020). Use of artificial intelligence in diagnosis of head and neck precancerous and cancerous lesions: A systematic review. Oral Oncol. 110: 104885. PMID: 32674040 doi: 10.1016/j.oraloncology.2020.104885
  112. Nagtegaal, I. D., Odze, R. D., Klimstra, D., Paradis, V., Rugge, M., Schirmacher, P., . . . Board, W. H. O. C. o. T. E. (2020). The 2019 WHO classification of tumours of the digestive system. Histopathology. 76(2): 182-188. PMID: 31433515 doi: 10.1111/his.13975
  113. Nicholson, A. G., Sauter, J. L., Nowak, A. K., Kindler, H. L., Gill, R. R., Remy-Jardin, M., . . . Galateau-Salle, F. (2020). EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach. J Thorac Oncol. 15(1): 29-49. PMID: 31546041 doi: 10.1016/j.jtho.2019.08.2506
  114. Patel, D. M., Jones, R. R., Booth, B. J., Olsson, A. C., Kromhout, H., Straif, K., . . . Ward, M. H. (2020). Parental occupational exposure to pesticides, animals and organic dust and risk of childhood leukemia and central nervous system tumors: Findings from the International Childhood Cancer Cohort Consortium (I4C). Int J Cancer. 146(4): 943-952. PMID: 31054169 doi: 10.1002/ijc.32388
  115. Preti, M., Rotondo, J. C., Holzinger, D., Micheletti, L., Gallio, N., McKay-Chopin, S., . . . Gheit, T. (2020). Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women. Infect Agent Cancer. 15: 20. PMID: 32266002 doi: 10.1186/s13027-020-00286-8
  116. Quezada-Marín, J. I., Lam, A. K., Ochiai, A., Odze, R. D., Washington, K. M., Fukayama, M., . . . Salto-Tellez, M. (2020). Gastrointestinal tissue-based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours. Histopathology. 77(3): 340-350. PMID: 32320495 doi: 10.1111/his.14120
  117. Rage, E., Richardson, D. B., Demers, P. A., Do, M., Fenske, N., Kreuzer, M., . . . Laurier, D. (2020). PUMA – pooled uranium miners analysis: cohort profile. Occup Environ Med. 77(3): 194-200. PMID: 32005674 doi: 10.1136/oemed-2019-105981
  118. Rusyn, I., Belpoggi, F., Camacho, L., Kafferlein, H. U., Cattley, R., Estill, C. F., . . . Grp, I. M. V. (2020). Carcinogenicity of some industrial chemical intermediates and solvents. Lancet Oncology. 21(1): 25-26. PMID: 31787538 doi: 10.1016/S1470-2045(19)30779-X
  119. Rydz, E., Hall, A. L., & Peters, C. E. (2020). Prevalence and Recent Trends in Exposure to Night Shiftwork in Canada. Ann Work Expo Health. 64(3): 270-281. PMID: 32020159 doi: 10.1093/annweh/wxaa001
  120. Salgado, R., Bellizzi, A. M., Rimm, D., Bartlett, J. M. S., Nielsen, T., Holger, M., . . . Cree, I. (2020). How current assay approval policies are leading to unintended imprecision medicine. Lancet Oncol. 21(11): 1399-1401. PMID: 33098760 doi: 10.1016/s1470-2045(20)30592-1
  121. Samet, J. M., Chiu, W. A., Cogliano, V., Jinot, J., Kriebel, D., Lunn, R. M., . . . Wild, C. P. (2020). The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification. J Natl Cancer Inst. 112(1): 30-37. PMID: 31498409 doi: 10.1093/jnci/djz169
  122. Schubauer-Berigan, M. K. (2020). Hazards at 10 000 m: studies of aircrew and their importance in understanding cancer risks from cosmic radiation and circadian disruption. Occup Environ Med. 77(5): 283-284. PMID: 32179634 doi: 10.1136/oemed-2020-106432
  123. Schüz, J., Bukhtiyarov, I., Olsson, A., Moissonnier, M., Ostroumova, E., Feletto, E., . . . Kovalevskiy, E. (2020). Occupational cohort study of current and former workers exposed to chrysotile in mine and processing facilities in Asbest, the Russian Federation: Cohort profile of the Asbest Chrysotile Cohort study. PLoS ONE. 15(7): e0236475. PMID: 32726334 doi: 10.1371/journal.pone.0236475
  124. Smith, M. T., Guyton, K. Z., Kleinstreuer, N., Borrel, A., Cardenas, A., Chiu, W. A., . . . Fielden, M. (2020). The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them. Cancer Epidemiol Biomarkers Prev. 29(10): 1887-1903. PMID: 32152214 doi: 10.1158/1055-9965.Epi-19-1346
  125. Steenland, K., Schubauer-Berigan, M. K., Vermeulen, R., Lunn, R. M., Straif, K., Zahm, S., . . . Pearce, N. (2020). Risk of Bias Assessments and Evidence Syntheses for Observational Epidemiologic Studies of Environmental and Occupational Exposures: Strengths and Limitations. Environ Health Perspect. 128(9): 95002. PMID: 32924579 doi: 10.1289/EHP6980
  126. Tan, P. H., Ellis, I., Allison, K., Brogi, E., Fox, S. B., Lakhani, S., . . . Cree, I. A. (2020). The 2019 World Health Organization classification of tumours of the breast. Histopathology. 77(2): 181-185. PMID: 32056259 doi: 10.1111/his.14091
  127. Uttley, L., Indave, B. I., Hyde, C., White, V., Lokuhetty, D., & Cree, I. (2020). Invited commentary-WHO Classification of Tumours: How should tumors be classified? Expert consensus, systematic reviews or both? Int J Cancer. 146(12): 3516-3521. PMID: 32170735 doi: 10.1002/ijc.32975
  128. Bamia, C., Turati, F., Guha, N., van den Brandt, P., Loomis, D., Ferraroni, M., . . . Guercio, V. (2019). The role of coffee consumption in breast and ovarian cancer risk: updated meta-analyses. Epidemiol Biostat Public Health. 16(1): e13078-13071 – e13078-13025. doi: 10.2427/13078
  129. Birkett, N., Al-Zoughool, M., Bird, M., Baan, R. A., Zielinski, J., & Krewski, D. (2019). Overview of biological mechanisms of human carcinogens. J Toxicol Env Health-Pt B-Crit Rev. 22(7-8): 288-359. doi: 10.1080/10937404.2019.1643539
  130. Brenner, D. R., Fehringer, G., Zhang, Z. F., Lee, Y. A., Meyers, T., Matsuo, K., . . . Straif, K. (2019). Alcohol consumption and lung cancer risk: A pooled analysis from the International Lung Cancer Consortium and the SYNERGY study. Cancer Epidemiol. 58: 25-32. PMID: 30445228 doi: 10.1016/j.canep.2018.10.006
  131. Dahm, M. M., Bertke, S., & Schubauer-Berigan, M. K. (2019). Predicting Occupational Exposures to Carbon Nanotubes and Nanofibers Based on Workplace Determinants Modeling. Ann. Work Expos. Health. 63(2): 158-172. doi: 10.1093/annweh/wxy102
  132. Grosse, Y., Lajoie, P., Billard, M., Krewski, D., Rice, J., Baan, R. A., . . . Zielinski, J. M. (2019). Development of a database on tumors and tumor sites in humans and in experimental animals for ‘Group 1 agents identified through volume 109 of the IARC Monographs. J Toxicol Environ Health B Crit Rev. 22(7-8): 237-243. PMID: 31612803 doi: 10.1080/10937404.2019.1642601
  133. Hall, A. L., Kecklund, G., Leineweber, C., & Tucker, P. (2019). Effect of work schedule on prospective antidepressant prescriptions in Sweden: a 2-year sex-stratified analysis using national drug registry data. BMJ Open. 9(1): e023247. PMID: 30782699 doi: 10.1136/bmjopen-2018-023247
  134. Honaryar, M. K., Lunn, R. M., Luce, D., Ahrens, W., t Mannetje, A., Hansen, J., . . . Guha, N. (2019). Welding fumes and lung cancer: a meta-analysis of case-control and cohort studies. Occup Environ Med. 76(6): 422-431. PMID: 30948521 doi: 10.1136/oemed-2018-105447
  135. Iavicoli, S., Driscoll, T. R., Hogan, M., Iavicoli, I., Rantanen, J. H., Straif, K., & Takala, J. (2019). New avenues for prevention of occupational cancer: a global policy perspective. Occup Environ Med. 76(6): 360-362. PMID: 31088975 doi: 10.1136/oemed-2018-105546
  136. Kelly-Reif, K., Sandler, D. P., Shore, D., Schubauer-Berigan, M., Troester, M. A., Nylander-French, L., & Richardson, D. B. (2019). Mortality and cancer incidence among underground uranium miners in the Czech Republic 1977-1992. Occup Environ Med. 76(8): 511-518. PMID: 31167952 doi: 10.1136/oemed-2018-105562
  137. Krewski, D., Bird, M., Al-Zoughool, M., Birkett, N., Billard, M., Milton, B., . . . Zielinski, J. M. (2019). Key characteristics of 86 agents known to cause cancer in humans. J Toxicol Environ Health B Crit Rev. 22(7-8): 244-263. PMID: 31637961 doi: 10.1080/10937404.2019.1643536
  138. Krewski, D., Rice, J. M., Bird, M., Milton, B., Collins, B., Lajoie, P., . . . Zielinski, J. M. (2019). Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans. J Toxicol Environ Health B Crit Rev. 22(7-8): 203-236. PMID: 31795923 doi: 10.1080/10937404.2019.1642586
  139. Lauby-Secretan, B., Dossus, L., Marant-Micallef, C., & His, M. (2019). [Obesity and Cancer]. Bull Cancer. 106(7-8): 635-646. PMID: 31227175 doi: 10.1016/j.bulcan.2019.04.008
  140. Leon, M. E., Schinasi, L. H., Lebailly, P., Beane Freeman, L. E., Nordby, K. C., Ferro, G., . . . Schuz, J. (2019). Pesticide use and risk of non-Hodgkin lymphoid malignancies in agricultural cohorts from France, Norway and the USA: a pooled analysis from the AGRICOH consortium. Int J Epidemiol. 48(5): 1519-1535. PMID: 30880337 doi: 10.1093/ije/dyz017
  141. Loomis, D., Guha, N., Kogevinas, M., Fontana, V., Gennaro, V., Kolstad, H. A., . . . Saracci, R. (2019). Cancer mortality in an international cohort of reinforced plastics workers exposed to styrene: a reanalysis. Occup Environ Med. 76(3): 157-162. PMID: 29669820 doi: 10.1136/oemed-2018-105131
  142. Malir, F., Louda, M., Ostry, V., Toman, J., Ali, N., Grosse, Y., . . . Degen, G. H. (2019). Analyses of biomarkers of exposure to nephrotoxic mycotoxins in a cohort of patients with renal tumours. Mycotoxin Res. 35(4): 391-403. PMID: 31254204 doi: 10.1007/s12550-019-00365-9
  143. Mandrik, O., Zielonke, N., Meheus, F., Severens, J. L. H., Guha, N., Herrero Acosta, R., & Murillo, R. (2019). Systematic reviews as a ‘lens of evidence’: Determinants of benefits and harms of breast cancer screening. Int J Cancer. 145(4): 994-1006. PMID: 30762235 doi: 10.1002/ijc.32211
  144. Marant Micallef, C., Shield, K. D., Vignat, J., Baldi, I., Charbotel, B., Fervers, B., . . . Soerjomataram, I. (2019). Cancers in France in 2015 attributable to occupational exposures. Int J Hyg Environ Health. 222(1): 22-29. PMID: 30174219 doi: 10.1016/j.ijheh.2018.07.015
  145. Marques, M., Berrington, d. G. A., Beland, F., Browne, P., Demers, P., Lachenmeier, D., . . . Guyton, K. (2019). Advisory Group recommendations on priorities for the IARC Monographs. Lancet Oncol. 20(6): 763-764. PMID: 31005580 doi: 10.1016/s1470-2045(19)30246-3
  146. Mehrotra, R., Yadav, A., Sinha, D. N., Parascandola, M., John, R. M., Ayo-Yusuf, O., . . . Gupta, P. C. (2019). Smokeless tobacco control in 180 countries across the globe: call to action for full implementation of WHO FCTC measures. Lancet Oncol. 20(4): E208-E217. doi: 10.1016/s1470-2045(19)30084-1
  147. Richmond, R. C., Anderson, E. L., Dashti, H. S., Jones, S. E., Lane, J. M., Strand, L. B., . . . Smith, G. D. (2019). Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study. BMJ. 365: l2327. PMID: 31243001 doi: 10.1136/bmj.l2327
  148. Salgado, R., Solit, D. B., Rimm, D. L., Bogaerts, J., Canetta, R., Lively, T., . . . Faculty, I. (2019). Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology. Eur J Cancer. 114: 128-136. PMID: 31060925 doi: 10.1016/j.ejca.2019.03.025
  149. Salto-Tellez, M., & Cree, I. A. (2019). Cancer taxonomy: pathology beyond pathology. Eur J Cancer. 115: 57-60. PMID: 31108243 doi: 10.1016/j.ejca.2019.03.026
  150. Steenland, K., Barry, V., Anttila, A., Sallmen, M., Mueller, W., Ritchie, P., . . . Straif, K. (2019). Cancer incidence among workers with blood lead measurements in two countries. Occup Environ Med. 76(9): 603-610. PMID: 31296664 doi: 10.1136/oemed-2019-105786
  151. White, V. (2019). Understanding and Classification of Ocular Lymphomas. Ocul Oncol Pathol. 5(6): 379-386. doi: 10.1159/000499845
  152. Zhivagui, M., Ng, A. W. T., Ardin, M., Churchwell, M. I., Pandey, M., Renard, C., . . . Zavadil, J. (2019). Experimental and pan-cancer genome analyses reveal widespread contribution of acrylamide exposure to carcinogenesis in humans. Genome Res. 29(4): 521-531. PMID: 30846532 doi: 10.1101/gr.242453.118

 

 

 

 

Evidence Synthesis and Classification
About Research Publications Related websites Personnel
Close Reading Mode
UP